How do you know that buyers are bulding already? Just curious.
I am not so much excited about the results. Granted this is a horrible type of cancer, the press relase is trying to pick sub-groups to show clinical benefit. I think it will be a hard-sell to find phase 3 sponsors with sub-group analysis. I hope I am wrong.